Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis

被引：0
|
作者：
A. Singer
M. R. McClung
O. Tran
C. D. Morrow
S. Goldstein
R. Kagan
M. McDermott
A. Yehoshua
机构：
[1] MedStar Georgetown University Hospital,
[2] Georgetown University Medical Center,undefined
[3] Oregon Osteoporosis Center,undefined
[4] Mary MacKillop Institute for Health Research,undefined
[5] Australian Catholic University,undefined
[6] Merative,undefined
[7] NYU Grossman School of Medicine,undefined
[8] University of California,undefined
[9] Amgen Inc,undefined
来源：
Archives of Osteoporosis | / 18卷
关键词：
Aged; Bone density/drug effects; Bone density conservation agents; Cost of illness; Female; Health care costs; Hospitalization; Humans; Medicare; Middle aged; Postmenopausal; Risk assessment; USA/epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
    Bell, Christopher F.
    Priest, Julie
    Stott-Miller, Marni
    Kan, Hong
    Amelio, Justyna
    Song, Xue
    Limone, Brendan
    Noxon, Virginia
    Costenbader, Karen H.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [22] Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma
    Fonseca, Rafael
    Abouzaid, Safiya
    Bonafede, Machaon
    Cai, Qian
    Parikh, Kejal
    Cosler, Leon
    Richardson, Paul
    BLOOD, 2016, 128 (22)
  • [23] Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies
    Thai, Sydney
    Zhuo, Joe
    Zhong, Yichen
    Xia, Qian
    Chen, Xiu
    Bao, Ying
    Dhanda, Devender
    Priya, Lawshia
    Wu, Jashin J. J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [24] Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study
    Murage, Mwangi J.
    Princic, Nicole
    Park, Julie
    Malatestinic, William
    Zhu, Baojin
    Atiya, Bilal
    Kern, Scott A.
    Stenger, Keri B.
    Sprabery, Aubrey Trevelin
    Ogdie, Alexis
    ACR OPEN RHEUMATOLOGY, 2021, 3 (12) : 879 - 887
  • [25] Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 531 - 542
  • [26] Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands
    Franken, Margreet G.
    Leeneman, Brenda
    Jochems, Anouk
    Schouwenburg, Maartje G.
    Aarts, Maureen J. B.
    van Akkooi, Alexander C. J.
    van den Berkmortel, Franchette W. P. . J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    van der Hoeven, Koos J. M.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Koornstra, Rutger
    Kruit, Wim H. J.
    Louwman, Marieke W. J.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    van Zeijl, Michiel
    Haanen, John B. A. G.
    Uyl-de Groot, Carin A.
    ANTI-CANCER DRUGS, 2018, 29 (06) : 579 - 588
  • [27] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [28] Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis
    Eloranta, S.
    Smedby, K. E.
    Dickman, P. W.
    Andersson, T. M.
    JOURNAL OF INTERNAL MEDICINE, 2021, 289 (01) : 12 - 28
  • [29] Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors
    Huynh, Lynn
    Cai, Beilei
    Cheng, Mu
    Lax, Angie
    Lejeune, Dominique
    Duh, Mei S.
    Kim, Michelle K.
    PANCREAS, 2019, 48 (09) : 1126 - 1135
  • [30] REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF PATIENTS UNDER QUADRUPLE COMBINATION OF ANTIHYPERTENSIVES IN ITALY
    Degli Esposti, L.
    Brouwers, S.
    Desideri, G.
    Perrone, V
    Narkiewicz, K.
    Mancia, G.
    VALUE IN HEALTH, 2022, 25 (12) : S93 - S93
12345